- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.03. | MARIMED INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12.03. | MariMed outlines 2026 growth strategy as wholesale revenue rises 11% and new state expansions advance | 2 | Seeking Alpha | ||
| 11.03. | MariMed Non-GAAP EPS of $2.20 beats by $2.21, revenue of $41.7M beats by $0.9M | 3 | Seeking Alpha | ||
| 11.03. | MariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2025 Earnings | 162 | GlobeNewswire (Europe) | NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen | |
| MARIMED Aktie jetzt für 0€ handeln | |||||
| 10.03. | An Overview of MariMed's Earnings | 1 | Benzinga.com | ||
| 02.03. | MariMed Inc.: MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure | 57 | GlobeNewswire (Europe) | NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or "the Company") (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today... ► Artikel lesen | |
| 11.02. | Marimed Inc: Marimed to release 2025 results March 11 | 2 | Stockwatch | ||
| 11.02. | MariMed Inc.: MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date | 1 | GlobeNewswire (USA) | ||
| 05.02. | Marimed Inc: Marimed's Betty's Eddies launches Berry In Love Betty | 2 | Stockwatch | ||
| 22.01. | Marimed Inc: Marimed rolls out Vibations THC in Rhode Island | 3 | Stockwatch | ||
| 22.01. | MariMed Inc.: MariMed Launches Hemp-Derived THC Products Under its Vibations Brand in Rhode Island | 1 | GlobeNewswire (USA) | ||
| 19.12.25 | Marimed Inc: Marimed welcomes cannabis as Schedule 3 drug in U.S. | 2 | Stockwatch | ||
| 18.12.25 | MariMed Inc.: MariMed Statement on Historic Rescheduling of Cannabis | 137 | GlobeNewswire (Europe) | NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following... ► Artikel lesen | |
| 08.12.25 | MariMed Inc.: Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries | 2 | GlobeNewswire (USA) | ||
| 18.11.25 | Marimed Inc: Marimed adds winter cranberry orange Betty's chew | 2 | Stockwatch | ||
| 18.11.25 | MariMed Inc.: MariMed's Betty's Eddies Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's | 1 | GlobeNewswire (USA) | ||
| 06.11.25 | MariMed GAAP EPS of -$0.01, revenue of $40.76M misses by $1.39M | 4 | Seeking Alpha | ||
| 06.11.25 | MARIMED INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11.25 | MariMed outlines national brand expansion and hemp entry while maintaining positive cash flow | 1 | Seeking Alpha | ||
| 05.11.25 | MariMed Inc.: MariMed Reports Third Quarter 2025 Earnings | 102 | GlobeNewswire (Europe) | NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,865 | -1,38 % | Panik vor Kursbeben: Das Zittern beginnt: Reißen die Tilray-Zahlen Canopy, Aurora & Co in die Tiefe? | © Foto: adobe.stock.comIn Kürze ist es soweit - Tilray wird frische Quartalszahlen vorlegen. Den Tilray-Zahlen kann man dabei durchaus richtungsweisenden Charakter zubilligen. Entsprechend dürften sie... ► Artikel lesen | |
| ABBVIE | 184,00 | +0,33 % | Ausblick auf AbbVie - Bounce vom Support | ||
| CANOPY GROWTH | 0,793 | -3,88 % | Canopy Growth Corp (2): Canopy Growth appoints Manner managing director, Storz | ||
| TILRAY BRANDS | 5,490 | -4,19 % | TD Cowen cuts Tilray stock price target on aluminum cost pressures | ||
| INNOCAN PHARMA | 3,920 | -2,97 % | Alarmstufe Rot - InnoCan Pharma-Aktie massiv gefährdet | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| DERMAPHARM | 41,100 | -7,64 % | EQS-News: Dermapharm Holding SE erwirbt im Rahmen ihres öffentlichen Aktienrückkaufangebots 4.299.190 eigene Aktien zurück | EQS-News: Dermapharm Holding SE
/ Schlagwort(e): Aktienrückkauf
Dermapharm Holding SE erwirbt im Rahmen ihres öffentlichen Aktienrückkaufangebots 4.299.190 eigene Aktien zurück... ► Artikel lesen | |
| CRONOS GROUP | 2,170 | -1,63 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 2,065 | -6,77 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures | Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,120 | -5,08 % | Organigram Global Inc: Organigram garners ISS support for Sanity transaction | ||
| GREEN THUMB INDUSTRIES | 5,505 | +2,80 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2025 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,142 | -1,47 % | SNDL Inc.: SNDL Reports Fourth Quarter and Full Year 2025 Financial and Operational Results | EDMONTON, Alberta, March 12, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter... ► Artikel lesen | |
| CRESCO LABS | 0,780 | +3,24 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 1,170 | 0,00 % | BC Securities Commission: BCSC halts Noveris Health after incorrect FDA claim |
MARIMED INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARIMED INC finden Sie auf Wallstreet Online.